141 related articles for article (PubMed ID: 2813261)
1. Saturable process involved in active efflux of vincristine as a mechanism of multidrug resistance in P388 leukemia cells.
Watanabe T; Inaba M; Sugiyama Y
Pharm Res; 1989 Aug; 6(8):690-6. PubMed ID: 2813261
[TBL] [Abstract][Full Text] [Related]
2. Kinetic analysis of active efflux of vincristine from multidrug-resistant P388 leukemia cells.
Inaba M; Watanabe T; Sugiyama Y
Jpn J Cancer Res; 1987 Apr; 78(4):397-404. PubMed ID: 3108219
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin.
Tsuruo T; Iida H; Yamashiro M; Tsukagoshi S; Sakurai Y
Biochem Pharmacol; 1982 Oct; 31(19):3138-40. PubMed ID: 7150340
[TBL] [Abstract][Full Text] [Related]
4. Reversal of multidrug resistance by an immunosuppressive agent FK-506.
Naito M; Oh-hara T; Yamazaki A; Danki T; Tsuruo T
Cancer Chemother Pharmacol; 1992; 29(3):195-200. PubMed ID: 1370765
[TBL] [Abstract][Full Text] [Related]
5. Correlates of vincristine resistance in four murine tumor cell lines.
Bender RA; Kornreich WD; Wodinsky I
Cancer Lett; 1982; 15(3):335-41. PubMed ID: 7116335
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of P-glycoprotein and alterations in topoisomerase II in P388 mouse leukemia cells selected in vivo for resistance to mitoxantrone.
Kamath N; Grabowski D; Ford J; Kerrigan D; Pommier Y; Ganapathi R
Biochem Pharmacol; 1992 Sep; 44(5):937-45. PubMed ID: 1356339
[TBL] [Abstract][Full Text] [Related]
7. Membrane transport of 1-beta-D-arabinofuranosylcytosine and accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in P388 murine leukemic cells resistant to vincristine.
Higashigawa M; Ido M; Kuwabara H; Hori H; Ohkubo T; Kawasaki H; Sakurai M; Taniguchi K; Hamazaki M
Leuk Res; 1991; 15(4):255-62. PubMed ID: 2030607
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of vincristine by vitamin A against drug-resistant mouse leukaemia cells.
Nogae I; Kikuchi J; Yamaguchi T; Nakagawa M; Shiraishi N; Kuwano M
Br J Cancer; 1987 Sep; 56(3):267-72. PubMed ID: 3663474
[TBL] [Abstract][Full Text] [Related]
9. Reversal of multidrug resistance by a novel quinoline derivative, MS-209.
Sato W; Fukazawa N; Nakanishi O; Baba M; Suzuki T; Yano O; Naito M; Tsuruo T
Cancer Chemother Pharmacol; 1995; 35(4):271-7. PubMed ID: 7828268
[TBL] [Abstract][Full Text] [Related]
10. Effect of glucose transport inhibitors on vincristine efflux in multidrug-resistant murine erythroleukaemia cells overexpressing the multidrug resistance-associated protein (MRP) and two glucose transport proteins, GLUT1 and GLUT3.
Martell RL; Slapak CA; Levy SB
Br J Cancer; 1997; 75(2):161-8. PubMed ID: 9010020
[TBL] [Abstract][Full Text] [Related]
11. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells.
Tsuruo T; Iida H; Kitatani Y; Yokota K; Tsukagoshi S; Sakurai Y
Cancer Res; 1984 Oct; 44(10):4303-7. PubMed ID: 6467192
[TBL] [Abstract][Full Text] [Related]
12. ATP/Mg2+-dependent binding of vincristine to the plasma membrane of multidrug-resistant K562 cells.
Naito M; Hamada H; Tsuruo T
J Biol Chem; 1988 Aug; 263(24):11887-91. PubMed ID: 3165378
[TBL] [Abstract][Full Text] [Related]
13. Effect of homoharringtonine on the viability of murine leukemia P388 cells resistant to either adriamycin, vincristine, or 1-beta-D-arabinofuranosylcytosine.
Wilkoff LJ; Dulmadge DA; Laster WR; Griswold DP
Cancer Chemother Pharmacol; 1989; 23(3):145-50. PubMed ID: 2924372
[TBL] [Abstract][Full Text] [Related]
14. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.
Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
Cancer Res; 1981 May; 41(5):1967-72. PubMed ID: 7214365
[TBL] [Abstract][Full Text] [Related]
15. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y
Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602
[TBL] [Abstract][Full Text] [Related]
16. Decreased DNA polymerase sensitivity to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in P388 murine leukemic cells resistant to vincristine.
Higashigawa M; Ido M; Nagao Y; Kuwabara H; Hori H; Ohkubo T; Kawasaki H; Sakurai M
Leuk Res; 1991; 15(8):675-81. PubMed ID: 1895749
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of the vincristine effect on P388 mouse leukemia cells by a newly synthesized dihydropyridine analogue, PAK-200.
Shudo N; Fujii R; Matsumoto T; Mizoguchi T; Seto K; Sakoda R; Akiyama S
Jpn J Cancer Res; 1992 Sep; 83(9):1011-7. PubMed ID: 1429198
[TBL] [Abstract][Full Text] [Related]
18. Active efflux common to vincristine and daunorubicin in vincristine-resistant P388 leukemia.
Inaba M; Fujikura R; Sakurai Y
Biochem Pharmacol; 1981 Jul; 30(13):1863-5. PubMed ID: 7271878
[No Abstract] [Full Text] [Related]
19. Selective enhancement of vincristine cytotoxicity in multidrug-resistant tumor cells by dilantin (phenytoin).
Ganapathi R; Hercbergs A; Grabowski D; Ford J
Cancer Res; 1993 Jul; 53(14):3262-5. PubMed ID: 8100737
[TBL] [Abstract][Full Text] [Related]
20. Acquired vs innate multidrug resistance and the effect of calcium channel blockers.
Tsuruo T
Prog Clin Biol Res; 1986; 223():203-16. PubMed ID: 3468516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
